Conclusion, Investment Implications, Strategy

We are exiting our April 28th long idea in Mylan N.V. (MYL) today for a 6% gain to avoid potential price volatility following the report of earnings before the market open on Monday Mat 11th.  The report will be for the fiscal Quarter ending March 2020. 

Analysis and Rationale

Mylan N.V. (MYL) is expected to report earnings on Monday 05/11/2020 before the market open. The report will be for the fiscal Quarter ending Mar 2020. According to Zacks Investment Research, based on 6 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.88.

Mylan N.V. (MYL), together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded-generic, brand-name, and over-the-counter (OTC) pharmaceutical products in North America, Europe, and internationally.